Page 3 - Best Targeted therapy doctors: TOP 68 doctors

Dr. Eckhart Weidemann leads the Hematology sector at Nordwest Clinic – a specialist in blood disorder treatment with 36 years of experience of experience.

• Specializes in non-Hodgkin lymphoma cases
• Heads hematology at Nordwest Clinic
• Professor with extensive academic background

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Clinical Director of the Multidisciplinary Breast Unit at Kliniken Essen-Mitte – Sherko Kuemmel leads advanced breast cancer research and treatment.

• 322 peer-reviewed publications on breast cancer
• Executive Board Member of the AGO – shaping breast cancer guidelines
• Leads international clinical trials as Global PI
• ESMO Faculty member for breast cancer education

Dr. Lucía González Cortijo leads the Oncology Department at Quirónsalud Madrid, specializing in breast and gynecologic cancers with 20+ years of experience.

• Expert in precision oncology and targeted therapies
• Principal investigator in 20+ clinical trials for advanced treatments
• Founder of initiatives supporting cancer patients' quality of life
• Member of ESMO, ASCO, and GEICAM

Specializing in advanced endoscopic procedures, Dr. Erdogan brings expertise in ERCP, EUS, and IBD treatment at İstinye University Liv Hospital Topkapı.

• Clinical fellowship in gastroenterology at Ankara City Hospital
• Published multiple research articles on inflammatory bowel disease treatment
• Experienced in peroral endoscopic myotomy (POEM) and endoscopic submucosal dissection (ESD)
• Active contributor to peer-reviewed journals in the field of gastroenterology

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Prof. Ben Boursi specializes in gastrointestinal oncology and microbiome research, pioneering innovative cancer therapies at Sheba Medical Center.

• Trained in gastrointestinal oncology at the University of Pennsylvania
• Founder of the ECOG-ACRIN Microbiome Working Group
• Published in top journals like Science
• Developed predictive models for early cancer detection
• Board-certified in internal medicine and medical oncology

Chief Physician of the Oncology Center at Assuta Medical Center – leading expert in targeted therapy.

• Specializes in precision oncology treatments
• Extensive experience with personalized cancer therapies
• Works at one of Israel's top cancer centers

Dr. Shaikh specializes in oral cancer surgeries with a focus on organ preservation and functional rehabilitation at HCG Manavata Cancer Centre.

• 15 years of experience of experience in surgical oncology
• Fellowship-trained in Head & Neck Surgical Oncology
• Proficient in major maxillofacial and head & neck surgeries
• Researcher with multiple publications

Dr. Raj Nagarkar has performed over 50,000+ cancer surgeries and led 200+ clinical trials, focusing on breast and thoracic surgical oncology.

• Trained at Tata Memorial Hospital and Royal College of Surgeons, Edinburgh
• Specializes in breast and thoracic surgical oncology
• Professor for DNB Superspecialty Surgical Oncology
• 30 years of experience of experience in surgical oncology
• Multiple international and national publications

Dr. Lalit has successfully performed over 10,000 major surgeries, with a focus on minimal invasive cancer surgeries at HCG Manavata Cancer Centre.

• 15 years of experience of experience in surgical oncology
• Fellowship at Tata Medical Centre with specialty in Gastrointestinal Cancer
• Assistant Professor at State Cancer Institute and Government Cancer Hospital
• Multiple national and international publications
• Patient-friendly and ethical approach

Dr. Joan Albanell Mestres leads HM Delfos' breast cancer program and has published 120+ articles with over 9,000 citations.

• MBBS from University Autónoma de Barcelona
• Residency at Vall d'Hebron clinic
• Conducted telomerase research in New York
• Director of cancer research at Del Mar
• Leading member of GEICAM, CIBERONC, AIECA, SEOM